Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Vascular Erectile Dysfunction
NCT02584686Phase 1Completed
- Sponsor
- Cairo University
- Start
- Oct 2015
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in erectile dysfunction (ED) (2 arms), sponsored by Cairo University. Primary endpoint: Cavernosal Artery Mean Peak Systolic Velocity at 2 weeks. Started Oct 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02584686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584686.